| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Jun 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.83B | 21.60B | 22.16B | 12.68B | 13.85B | 13.55B |
| Gross Profit | 2.89B | 6.85B | 8.83B | 5.52B | 6.17B | 8.00B |
| EBITDA | -18.76B | -13.55B | 6.92B | 296.70M | 4.91B | 2.26B |
| Net Income | -14.84B | -10.35B | 5.01B | 123.10M | 694.68M | 1.45B |
Balance Sheet | ||||||
| Total Assets | 56.79B | 84.94B | 133.83B | 93.83B | 70.76B | 85.77B |
| Cash, Cash Equivalents and Short-Term Investments | 10.58B | 20.04B | 17.98B | 10.93B | 11.33B | 13.10B |
| Total Debt | 32.89B | 56.56B | 94.25B | 60.74B | 37.72B | 53.73B |
| Total Liabilities | 34.52B | 58.60B | 97.38B | 62.83B | 39.86B | 58.26B |
| Stockholders Equity | 22.27B | 26.33B | 36.45B | 30.99B | 30.88B | 27.49B |
Cash Flow | ||||||
| Free Cash Flow | 13.27B | -12.98B | -27.33B | -21.84B | 8.49B | -17.70B |
| Operating Cash Flow | 13.30B | -12.76B | -27.07B | -21.71B | 8.63B | -17.54B |
| Investing Cash Flow | 1.24B | 48.28B | 863.90M | -1.75B | 362.18M | 4.82B |
| Financing Cash Flow | -21.86B | -37.12B | 32.05B | 24.33B | -13.07B | 23.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | ₹31.82B | 12.44 | ― | 0.29% | 11.75% | -6.52% | |
61 Neutral | ₹15.86B | 18.43 | ― | ― | -6.03% | -100.77% | |
51 Neutral | ₹25.69B | 19.28 | ― | ― | -10.17% | -181.71% | |
51 Neutral | ₹13.14B | 10.24 | ― | ― | ― | ― | |
48 Neutral | ₹18.39B | -5.67 | ― | ― | -45.13% | -1646.01% | |
46 Neutral | ₹11.91B | -3.33 | ― | ― | 47.88% | 11.61% |
Spandana Sphoorty Financial Limited has notified stock exchanges that the audio recording of its investors and analysts conference call discussing the unaudited consolidated and standalone financial results for the third quarter and nine months ended 31 December 2025 has been uploaded to the company’s website. The firm added that a detailed transcript of the call will be filed with the exchanges and made available online in due course, improving disclosure and access to its financial commentary for shareholders and market participants.
Spandana Sphoorty Financial Limited has disclosed that CARE Ratings Limited, acting as the appointed monitoring agency, has submitted its report for the quarter ended 31 December 2025 on the utilisation of proceeds from the company’s Rs 400 crore rights issue of equity shares. The filing, made to both BSE and NSE in compliance with SEBI listing and capital-raising regulations, signals that the deployment of rights issue funds is being independently reviewed and formally reported, underscoring governance, regulatory adherence and transparency for investors and other stakeholders; the company has also made the monitoring report available on its website for public access.